CELULARITY INC-A(NASDAQ:CELU) stock News

CELU Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Benzinga - Mentions: XRAY CCM SSKN SNOA ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

8 days ago - By: Celularity Inc.

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

23 days ago - By: Benzinga - Mentions: RDHL CLLS MRUS MLTX ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

5 months ago - By: Celularity Inc.

Celularity Receives Nasdaq Notice Regarding Form 10-Q

6 months ago - By: Celularity Inc.

Celularity Announces Full Year 2024 Operating and Financial Results

6 months ago - By: Celularity Inc.

Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees

11 months ago - By: Celularity Inc.

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

a year ago - By: Celularity Inc.

Celularity Inc. Announces Receipt of Nasdaq Notification

a year ago - By: Celularity Inc.

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

2 months ago - By: Celularity, Inc.

Celularity Receives Nasdaq Notice Regarding Form 10-Q

3 months ago - By: Celularity, Inc.

Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law

4 months ago - By: Celularity, Inc.

Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies

4 months ago - By: Celularity, Inc.

Celularity Announces Chief Financial Officer Transition

6 months ago - By: Celularity Inc.

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products

8 months ago - By: Celularity Inc.

Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products

11 months ago - By: Celularity Inc.

Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023

a year ago - By: Celularity Inc.

CELULARITY INC-A (CELU) Stock News

CELU Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Tuesday's After-Market Session

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

12 Health Care Stocks Moving In Monday's Pre-Market Session

Celularity Receives Nasdaq Notice Regarding Form 10-Q

Celularity Announces Full Year 2024 Operating and Financial Results

Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

Celularity Inc. Announces Receipt of Nasdaq Notification

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

Celularity Receives Nasdaq Notice Regarding Form 10-Q

Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law

Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies

Celularity Announces Chief Financial Officer Transition

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products

Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products

Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023

Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific